CASE 12 MID-ATLANTIC SPECIALTY, INC: Financial Risk | 12/1/17 | ||||||
Copyright 2018 Foundation of the American College of Healthcare Executives. Not for sale. | |||||||
Model without Questions, Student Version | |||||||
Case 12 deals with basic financial risk concepts of a medical group practice facing alternative | |||||||
investment opportunities. | |||||||
The student version of the model is a format guide only because the objective is for students to attempt | |||||||
basic calculations themselves. The key to student success in this case lies in correct calculations and | |||||||
interpretation of the data. | |||||||
Estimated one-year return distributions: | |||||||
State of the | 1-Year | Healthcare | Inverse | Biotech | S&P | ||
Economy | Probability | T-Bill | Fund | ETF | Fund | 500 | |
Poor | 0.1 | 7% | -8% | 18% | -19% | -15% | |
Below average | 0.2 | 7% | 2% | 23% | 0% | 0% | |
Average | 0.4 | 7% | 14% | 7% | 13% | 15% | |
Above average | 0.2 | 7% | 25% | -3% | 31% | 30% | |
Excellent | 0.1 | 7% | 33% | 2% | 50% | 45% | |
Historical return distributions: |
1-Year | Healthcare | Inverse | Biotech | S&P | |||
T-Bill | Fund | ETF | Fund | 500 | |||
Year 1 | 7% | -8% | 18% | -19% | -15% | ||
Year 2 | 7% | 2% | 23% | 0% | 0% | ||
Year 3 | 7% | 14% | 7% | 13% | 15% | ||
Year 4 | 7% | 25% | -3% | 31% | 30% | ||
Year 5 | 7% | 33% | 2% | 50% | 45% | ||
Stand-alone return and risk: | |||||||
1-Year | Healthcare | Inverse | Biotech | S&P | |||
T-Bill | Fund | ETF | Fund | 500 | |||
Expected return [E(R)] | |||||||
Variance (Var) | |||||||
Standard deviation (SD) | |||||||
Coefficient of variation (CV) |
Portfolio return and risk: | |||||||
E(R) of | E(R) of | ||||||
Portfolio | Portfolio | ||||||
State of the | Healthcare Fund / | Healthcare Fund / | |||||
Economy | Inverse ETF | Biotech Fund | |||||
Poor | |||||||
Below average | |||||||
Average | |||||||
Above average | |||||||
Excellent | |||||||
Portfolio | Portfolio | ||||||
Healthcare Fund / | Healthcare Fund / | ||||||
Inverse ETF | Biotech Fund | ||||||
Expected return [E(R)] | |||||||
Variance (Var) | |||||||
Standard deviation (SD) | |||||||
Coefficient of variation (CV) | |||||||
Correlation coefficient |
Market characteristic lines: | |||||||
S&P | 1-Year | Healthcare | Inverse | Biotech | |||
500 | T-Bill | Fund | ETF | Fund | |||
Intercept | |||||||
Market beta | |||||||
Data point | |||||||
Data point | |||||||
Data point | |||||||
Data point | |||||||
Data point | |||||||
Market Characteristic Lines | |||||||
|
|||||||
Security market line: | |||||||
1-Year | Healthcare | Inverse | Biotech | ||||
T-Bill | Fund | ETF | Fund | ||||
Risk-free rate | |||||||
Required market return | |||||||
Market beta | |||||||
Investment required return | |||||||
Investment expected return | |||||||
Difference | |||||||
Security Market Line | |||||||
Historical returns for the various investment options are given below,
1-Year | Healthcare | Inverse | Biotech | S&P | |||
T-Bill | Fund | ETF | Fund | 500 | |||
Year 1 | 7% | -8% | 18% | -19% | -15% | ||
Year 2 | 7% | 2% | 23% | 0% | 0% | ||
Year 3 | 7% | 14% | 7% | 13% | 15% | ||
Year 4 | 7% | 25% | -3% | 31% | 30% | ||
Year 5 | 7% | 33% | 2% | 50% | 45% |
For the year 6 the expected return from the investment as per different economic scenario is given below
Estimated one-year return distributions: | |||||||
State of the | 1-Year | Healthcare | Inverse | Biotech | S&P | ||
Economy | Probability | T-Bill | Fund | ETF | Fund | 500 | |
Poor | 0.1 | 7% | -8% | 18% | -19% | -15% | |
Below average | 0.2 | 7% | 2% | 23% | 0% | 0% | |
Average | 0.4 | 7% | 14% | 7% | 13% | 15% | |
Above average | 0.2 | 7% | 25% | -3% | 31% | 30% | |
Excellent | 0.1 | 7% | 33% | 2% | 50% | 45% |
Expected return for each investment in year 6 will be,
1 Year T bill = .1 * 7 + .2 * 7 + .4 * 7 + .2 * 7 + .1 * 7 = .7 + 1.4 + 2.8 + 1.4 + .7 = 7 %
Health Care Fund = .1 * -8 + .2 * 2 + .4 * 14 + .2 * 25 + .1 * 33 = -.8 + .4 + 5.6 + 5 + 3.3 = 13.5 %
Inverse ETF = .1 * 18 + .2 * 23 + .4 * 7 + .2 * -3 + .1 * 2 = 1.8 + 4.6 + 2.8 -.6 + .2 = 8.8 %
Biotech Fund = .1 * - 19 + .2 * 0 + .4 * 13 + .2 * 31 + .1 * 50 = -1.9 + 0 + 5.2 + 6.2 + 5 = 14.5 %
S & P 500 = .1 * - 15 + .2 * 0 + .4 * 15 + .2 * 30 + .1 * 45 = -1.5 + 0 + 6 + 6 + 4,5 = 15 %
Variance of each of the investment can be calculatted as,
1 Year T bill = VAR(7,7, 7,7,7,7) = 0
Health Care Fund = VAR(8, 2,14 ,25,33,13.5) = 221.3
Inverse ETF = VAR(18 ,23, 7, -3 ,2 ,8.8) = 94.7
Biotech Fund = VAR(19, 0 ,13 ,31,50,14.5) = 573.2
S & P 500 = VAR(-15 ,0 ,15 ,30 ,45 ,15) = 450
Standard deviation for each of the investment,
1 Year T bill = STDEV(7,7, 7,7,7,7) = 0
Health Care Fund = STDEV(8, 2,14 ,25,33,13.5) = 14.8
Inverse ETF = STDEV(18 ,23, 7, -3 ,2 ,8.8) = 9.7
Biotech Fund = STDEV(19, 0 ,13 ,31,50,14.5) = 23.9
S & P 500 = STDEV(-15 ,0 ,15 ,30 ,45 ,15) = 21.2
Average return for each of the investment,
1 Year T bill = AVERAGE(7,7, 7,7,7,7) = 7
Health Care Fund = AVERAGE(8, 2,14 ,25,33,13.5) = 13.2
Inverse ETF =AVERAGE(18 ,23, 7, -3 ,2 ,8.8) = 9.3
Biotech Fund =AVERAGE(19, 0 ,13 ,31,50,14.5) = 14.9
S & P 500 = AVERAGE(-15 ,0 ,15 ,30 ,45 ,15) = 15
Coefficient of variation (CV) for each investment is the deviation per unit of return,
1 Year T bill = 0/7 = 0
Health Care Fund = 14.8/13.2 = 1.12
Inverse ETF = 9.7/9.3 = 1.04
Biotech Fund = 23.9/14.9 = 1,6
S & P 500 = 21.2/15 = 1.4
N.B - As part of HOMEWORKLIB RULES we can answer first four of any multipart question.
CASE 12 MID-ATLANTIC SPECIALTY, INC: Financial Risk 12/1/17 Copyright 2018 Foundation of the American College of...
Economic state Probability T-Bill Alta Indus. Repo Men American Foam Market Port.(index) Recession 0.1 8.00% -22.0% 28.0% 10.0% -13.0% Below Average 0.2 8.00% -2.0% 14.7% -10.0% 1.0% Average 0.4 8.00% 20.0% 0.0% 7.0% 15.0% Above Average 0.2 8.00% 35.0% -10.0% 45.0% 29.0% Boom 0.1 8.00% 50.0% -20.0% 30.0% 43.0 Barney Smith Investment Advisors recently issued estimates for the state of the economy and the rate of return on each state of the economy. Alta Industries, Inc. is an electronics firm;...
1. Consider historical data showing that the average annual rate of return on the S&P 500 portfolio over the past 85 years has averaged roughly 8% more than the Treasury bill return and that the S&P 500 standard deviation has been about 20% per year. Assume these values are representative of investors' expectations for future performance and that the current T-bill rate is 5%. Calculate the expected return and variance of portfolios invested in T-bills and the S&P 500 index...
Please use the following formulas to answer the question:
4. An investor has a risk aversion of 4. If she wants to invest all her wealth in the stock market that has a standard deviation of 16%. What is the implied risk premium of the market? What is the market risk premium if she has a risk aversion of only 2? 1. Arithmetic average stock returns .-= (+r)x(1+r)x.X(1+r)]š –1 = 19+r)*-1 2. Geometric average stock returns 3. APR versus EAR:...
PART III RISK AND RETURN Cell for "2" State of the Economy Worst case Poor case Most likely Good case Best case Return on Probability Treasury of Bond in Occurrence Upcoming Year 0.10 -0.34 0.20 -0.04 0.40 0.06 0.20 0.16 0.10 0.26 1.00 0.04000 0.02360 0.15362 3.84057 Expected return Variance STDEV CV You were provided with the above information about T-bills. Answer the following questions in the paces provided: 1. What does the expected return represent, and how is it...
You have 3 billion dollars in the fund, which you can invest in any combination of Australian stocks, US stocks, and Australian Treasury. The idea is to use your knowledge of portfolio theory to make an argument for having an internationally diversified portfolio, rather than just holding domestic assets. The data are monthly returns and the relevant sample statistics are summarized in the following table: Stock E[R] Var(R] Cov(Aus, US) Aus Index 0.00959 0.00222 0.00088 US Index 0.00727 0.00348 Aus...
B. MICFUELUNUML U C. idiosyncratic risk CD. systematic risk 0.5. Which of thes A. II,IV B. II,IV.v C. 1,111,1V ck A and Z have a correlation 05 D. 1,111, E. I, 3 Stock A and Stock B have a correlation Correlation-0.7, Stock A and Z have than a portfolio of story are an in is part of market A. Stock A and Z have a stronge CB. A portfolio of stock A and B P C C. Stock A and...
MULTIPLE CHOICE: 1. What is the long-run objective of financial management? A. Maximize earnings per share B. Maximize the value of the firm's common stock C. Maximize return on investment D. Maximize market share 2. Which of the following statement (in general) is correct? A. A low receivables turnover is desirable B. The lower the total debt-to-equity ratio, the lower the financial risk for a firm C. An increase in net profit margin with no change in sales or assets means a weaker ROI...
Morningstar Analyst Rating NAV T. Rowe Price Blue Chip Growth Fund TRBCX NAV $ NAV Day Change % Yield TTM Total Assets $ Status 70.53 0.370.53 0.00 30.7 Open Growth of 10,000 06-06-2006 - 06-06-2016 -- - - Min. Inv. Load Expenses Morningstar Rating Category Investment Style $2.500 Nong 0.71% Large Growth Large Growth 3 Year Average Morningstar Risk Measures Row Price Blue Chio Category Growth Fund 240123 Avg (1467 - Large Growth $1952763 P 500 TRUSD 1206 Returns. Category...
(1 point) The Capital Asset Price Model (CAPM) is a financial model that attempts to predict the rate of return on a financial instrument such as a common stock, in such a way that it is linearly related to the rate of return on the overal market. Specifically, RStockAd Bo+ PRMarket + e You are to study the relationship between the two variables and estimate the above model: 1,2,, 59 RStock Ad-rate of return on Stock A for month i,...
Morningstar Analyst Rating NAV T. Rowe Price Blue Chip Growth Fund TRBCX NAV $ NAV Day Change % Yield TTM Total Assets $ Status 70.53 0.370.53 0.00 30.7 Open Growth of 10,000 06-06-2006 - 06-06-2016 -- - - Min. Inv. Load Expenses Morningstar Rating Category Investment Style $2.500 Nong 0.71% Large Growth Large Growth 3 Year Average Morningstar Risk Measures Row Price Blue Chio Category Growth Fund 240123 Avg (1467 - Large Growth $1952763 P 500 TRUSD 1206 Returns. Category...